Covered recipient · General Payments record
KELLY K OCONNOR
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$2,505.08
- Reported across 36 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $663.74 | 8 |
| Education | $27.27 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Tempus AI, Inc | $134.53 | 2 |
| Axsome Therapeutics, Inc. | $124.99 | 1 |
| Alkermes, Inc. | $120.00 | 1 |
| E.R. Squibb & Sons, L.L.C. | $88.22 | 2 |
| Vanda Pharmaceuticals Inc. | $87.08 | 1 |
| Teva Pharmaceuticals USA, Inc. | $86.26 | 1 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $49.93 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alkermes, Inc. | $120.00 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120565021 | CMS |
| Axsome Therapeutics, Inc. | $124.99 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148377254 | CMS |
| E.R. Squibb & Sons, L.L.C. | $27.27 | 10/01/2024 | Education | Undisputed | 01/23/2026 | 1101224981 | CMS |
| E.R. Squibb & Sons, L.L.C. | $60.95 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101225027 | CMS |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $49.93 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118843075 | CMS |
| Tempus AI, Inc | $13.33 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150185302 | CMS |
| Tempus AI, Inc | $121.20 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150185304 | CMS |
| Teva Pharmaceuticals USA, Inc. | $86.26 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151713911 | CMS |
| Vanda Pharmaceuticals Inc. | $87.08 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133961481 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.